Health Care Delivery

Individuals who enrolled in health insurance on the Affordable Care Act's marketplaces had lower average drug spending and were less likely to use most medication classes than patients with employer-sponsored coverage, according to a study published in Health Affairs.

Introduced with good intent, some of the provisions of the Orphan Drug Act may compel the FDA to rethink its strategy.

A review of the benefit design choices made by states that expanded Medicaid (as of the end of 2014), revealed that states are offering more generous coverage that what is required under federal law, according to researchers with The Commonwealth Fund.

Consumer protections and rules to promote the march to value-based care are highlights of the massive proposal.

Innovative care delivery programs intended to improve quality and reduce costs need sustainable business models in order to last beyond the end of grants or other methods of time-limited funding. RAND researchers take a look at methods Massachusetts health plans and accountable care organizations are using.

The Obama Administration says that Florida can receive $1 billion this year and $600 million next year to pay for uncompensated care in safety net hospitals. However, the administration made it clear that more funding awaits the state if Medicaid expansion reaches those up to 138% of the federal poverty line.

Consumers with chronic diseases face challenging trade-offs when choosing health coverage, especially when it comes to out-of-pocket drug costs.

The implementation of the Affordable Care Act and its resulting market turbulence has not created the operation challenges for payers that was expected, according to a report from athenahealth, Inc.